The global Gynecological Drugs Market reached a value of USD 15.34 Billion in 2022 and is projected to experience a compound annual growth rate (CAGR) of 7.4% throughout the forecast period. Key drivers of market revenue growth include the increasing prevalence of gynecological cancer, growing health awareness among individuals, rising investments in medicine and drug development, and...